<DOC>
	<DOCNO>NCT02010931</DOCNO>
	<brief_summary>A retrospective analysis historical data look relapse free survival overall survival rate adult philadelphia negative B-pre-cursor acute lymphoblastic leukemia patient .</brief_summary>
	<brief_title>Retrospective Analysis Survival Adult MRD Positive Acute Lymphoblastic Leukemia Patients</brief_title>
	<detailed_description>A retrospective observational study review historical survival data ( relapse free survival overall survival ) adult patient philadelphia negative B-precursor acute lymphoblastic leukemia , complete hematological remission minimal residual disease .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>patient Philadelphianegative BPrecursor Acute Lyphmoblastic Leukemia complete hematological remission define less 5 % blast bone marrow least 3 intensive chemotherapy block ( i.e . standard investigational regimen accord adult protocol long 3 age appropriate chemotherapy block give , also include relapse treatment detection minimal residual disease ( molecular failure molecular relapse ) level great equal 10* ( 4 ) PCR great equal 10* ( 3 ) flow cytometry reference lab Age 15 great time initial diagnosis acute lymphoblastic leukemia . For patient aged 1517 treatment accord adult protocol require Initial diagnosis year 2000 late History acute lymphoblastic leukemia treatment ( include response first therapy , number prior relapse ) available Relapse status disease follow timepoint minimal residual disease detection available Patients extramedullary disease timepoint minimal residual disease detection Use Blinatumomab within 18 month minimal residual disease detection Allogeneic hematopoietic stem cell transplantation prior minimal residual disease detection require level</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>